News & Analysis on Clinical Trial Services & Contract Research And Development
Medidata: acquisition of MC10’s digital biomarker business
By Jenni Spinner
- Last updated on
Medidata, a Dassault Systèmes company, has acquired the digital biomarker business of MC10. The acquired company’s technologies reportedly will enhance Medidata’s capabilities of integrating data from wearable sensors – including clinical grade metrics – to help customers virtualize clinical trials.
According to Anthony Costello, senior vice president of mobile health for Medidata, “Incorporating remote biometric data capture and analysis that includes the MC10 nPoint Biostamp, alongside other leading mobile devices, will further strengthen the Medidata platform and help propel the digital transformation of life sciences.”